» Authors » M Gjurasin

M Gjurasin

Explore the profile of M Gjurasin including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 64
Citations 253
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sikiric P, Seiwerth S, Mise S, Staresinic M, Bedekovic V, Zarkovic N, et al.
Burns . 2003 Jun; 29(4):323-34. PMID: 12781609
The amelioration of corticosteroid-impairment of healing by a stable gastric pentadecapeptide BPC-157 (GEPPPGKPADDAGLV, M(w) 1419, currently in early clinical trials for inflammatory bowel disease) was studied in thermally injured mice....
2.
Prkacin I, Separovic J, Aralicia G, Perovic D, Gjurasin M, Stancic-Rokotov D, et al.
J Physiol Paris . 2001 Oct; 95(1-6):315-24. PMID: 11595456
Liver lesions and portal hypertension in rats, following chronic alcohol administration, are a particular target for therapy. Portal hypertension (mm Hg) assessed directly into the portal vein, and liver lesions...
3.
Stancic-Rokotov D, Slobodnjak Z, Aralica J, Aralica G, Perovic D, Staresinic M, et al.
J Physiol Paris . 2001 Oct; 95(1-6):303-8. PMID: 11595454
Anti-ulcer agents may likely attenuate lesions outside the gastrointestinal tract, since they had protected gastrectomized rats (a "direct cytoprotective effect"). Therefore, their therapeutic potential in lung/stomach lesions were shown. Rats...
4.
Prkacin I, Aralica G, Perovic D, Separovic J, Gjurasin M, Stancic-Rokotov D, et al.
J Physiol Paris . 2001 Oct; 95(1-6):295-301. PMID: 11595453
Unlike severe gastric damage acutely induced by ethanol administration in rat, the ulcerogenic effect of chronic alcohol administration (3.03 g/kg b.w. or 7.28 g/kg b.w.) given in drinking water, producing...
5.
Stancic-Rokotov D, Sikiric P, Seiwerth S, Slobodnjak Z, Aralica J, Aralica G, et al.
J Physiol Paris . 2001 Oct; 95(1-6):289-93. PMID: 11595452
Hemorrhagic mucosal lesions in the stomach in the rat induced by an intragastrical application of 1 ml of 50 or 75% ethanol were aggravated by preceding lung damage provoked by...
6.
Sikiric P, Seiwerth S, Aralica G, Perovic D, Staresinic M, Anic T, et al.
J Physiol Paris . 2001 Oct; 95(1-6):283-8. PMID: 11595451
After demonstration that cysteamine induced duodenal lesions in gastrectomized rats, while a number of antiulcer drugs mitigated these lesions, it was shown that one single intrarectal (i.r.) cysteamine application produced...
7.
Sikiric P, Seiwerth S, Grabarevic Z, Balen I, Aralica G, Gjurasin M, et al.
J Physiol Paris . 2001 Oct; 95(1-6):261-70. PMID: 11595448
Recently, we showed cysteamine-duodenal lesions without gastric acid, since they were induced also in gastrectomized rats, as in naive rats, and they were inhibited by the novel stomach pentadecapeptide BPC...
8.
Sikiric P, Separovic J, Anic T, Buljat G, Mikus D, Seiwerth S, et al.
J Physiol Paris . 2000 Feb; 93(6):479-85. PMID: 10672992
A clear protection of the gastrointestinal tract and an evident anti-inflammatory effect were shown for a novel stomach pentadecapeptide BPC 157 (i.p./i.g.) in comparison with several reference standards in various...
9.
Sikiric P, Jadrijevic S, Seiwerth S, Sosa T, Deskovic S, Perovic D, et al.
J Physiol Paris . 2000 Feb; 93(6):467-77. PMID: 10672991
Recently, the effectiveness of pentadecapeptide BPC 157 and other anti-ulcer agents, called 'direct cytoprotection', was evidenced in totally gastrectomized rats duodenum challenged with cysteamine 24 h after surgery, and sacrificed...
10.
Sikiric P, Seiwerth S, Grabarevic Z, Rucman R, Petek M, Jagic V, et al.
Eur J Pharmacol . 1997 Jul; 332(1):23-33. PMID: 9298922
The known effects of a novel stomach pentadecapeptide BPC157 (10 microg or 10 ng/kg), namely its salutary activity against ethanol (96%, i.g.)-induced gastric lesions (simultaneously applied i.p.) and in blood...